Emera Inc. (EMA)
Toronto Exchange · Canada · prices in CAD · close of 23 Oct 2026
Key indicators
| Last close | CAD 68.65 |
|---|---|
| 52-week range | 64.62 – 77.99 |
| Return, 1 month / 3 months | +0.9% / −10.2% |
| Return, 1 year / 3 years | +3.6% / +79.3% |
| Trend | Below its 200-day average |
| RSI (14) | 56 |
| Volatility (1 year) | 15.5% |
| Worst drawdown (1 year) | -15.4% |
| Average daily value traded | 100.74M CAD |
| Dividend yield | 4.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Emera Inc. is an energy company based in Halifax, Nova Scotia. It owns regulated electric and gas utilities that generate, transmit and distribute power to homes and businesses, chiefly through Nova Scotia Power in its home province, along with utility operations in the United States and the Caribbean. The company also holds interests in other energy businesses, including electricity transmission and renewable generation projects, serving residential, commercial and industrial customers across its service territories.
Emera Inc. trades under the code EMA on the Toronto Exchange in Canada, with its price quoted in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Emera Inc. (EMA) trades on the Toronto Exchange in Canada. It last closed at CAD 68.65 on 23 October 2026.
Its price-based Market X-Ray is 66 out of 100 (a fair price profile), ranking 208 of 870 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 3.6% and over the last three months it fell 10.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 52 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -2.3% | ||
| From 52-week high | -11.4% | ||
| Momentum | 39 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -10.2% | ||
| 6-month return | -2.2% | ||
| 12-month return, skipping the last month | 2.7% | ||
| Stability (higher is calmer) | 89 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 15.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -15.4% | ||
| Liquidity | 95 · Strong | Trades actively. | |
| Average daily value traded | 100.74M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 67 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.3% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +1.7% |
|---|---|
| 1 month | +0.9% |
| 3 months | −10.2% |
| 6 months | −2.2% |
| 1 year | +3.6% |
| 3 years | +79.3% |
| 5 years | +51.3% |
Signals
| 50-day / 200-day average | 68.51 / 70.24 |
|---|---|
| Golden / death cross (60 days) | Death, 12 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.24 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Oct 2026 | CAD 0.7400 |
| 31 Jul 2026 | CAD 0.7330 |
| 1 May 2026 | CAD 0.7330 |
| 30 Jan 2026 | CAD 0.7330 |
| 31 Oct 2025 | CAD 0.7330 |
| 1 Aug 2025 | CAD 0.7250 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.